Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2003
03/13/2003US20030049327 Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049255 Interleukin-1 receptors in the treatment of diseases
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049244 Method of utilizing neurotrophins to manipulate reproductive capacity
03/13/2003US20030049240 Pet food composition for treating helicobacter species in pets
03/13/2003US20030049211 Remedies and preventives for dental diseases
03/13/2003US20030049208 For delivering a medicant; product includes a coating having a medicament or agent; bioavailabilty; chewing gum product that releases caffiene for improved performance
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459413A1 Methods for sterilizing preparations containing albumin
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2458963A1 Increased solubility flavanolignan preparations
03/13/2003CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003CA2458820A1 Agent for suppression of hepatitis b virus replication
03/13/2003CA2458213A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
03/13/2003CA2457922A1 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
03/13/2003CA2452044A1 Pre-mixes of glp-1 and basal insulin
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291358A1 Feline hepatocyte growth factor
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1291022A1 Methods of using lanreotide, a somatostatin analogue
03/12/2003EP1291021A2 Pharmaceutical formulations for thyroid hormones
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1290952A1 Compositions for taking dietary fibers
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290143A2 Method to determine the differentiation potential of a target cell
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/12/2003EP1290021A2 Polynucleotide sequence encoding a putative cell adhesion molecule
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289989A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289561A2 Ligand conjugates and methods for preparing same
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289547A2 Immunization through oral administration of a vaccine with an edible product
03/12/2003EP1289536A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
03/12/2003EP1083891B1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
03/12/2003EP0984773B1 Pharmaceutical formulation of omeprazole
03/12/2003EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa
03/12/2003CN1402780A 感染性克隆 Infectious clone
03/12/2003CN1402729A Polycycloalkylpurines as adenosine receptor antagonists
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402709A 4-pyridinyl-N-acyl-L-phenylalanines
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1401390A Immunoregulation medicine-antibody poietins, preparing process and use thereof
03/12/2003CN1401389A Hepatitis B vaccine preparation
03/12/2003CN1401385A Summer heat relieving and lithagogue beverage and producing process thereof
03/12/2003CN1401378A Chinese medicine composition for treating colitis
03/12/2003CN1401376A Green tea polyphenol anti-caries coating film
03/12/2003CN1401374A Semifluid motherwort extract and producing process thereof
03/12/2003CN1401363A External applied medicine for treating hepatitis
03/12/2003CN1401361A Medicine for treating aphtha
03/12/2003CN1401358A Medicine for treating hepatitis, and preparing process thereof
03/12/2003CN1401340A Health product for liver cancer and preparing process thereof
03/12/2003CN1401338A Buccal tablet with pharynx purging and intestine lubricating action
03/12/2003CN1401337A Chinese medicine health product with adjusting action of enterogastric function
03/12/2003CN1401335A Medicine for withdrawal of drug addiction and preparing process thereof
03/12/2003CN1401330A Buccal red deer horn tablet
03/12/2003CN1401317A Use of bismuth subgallate in suppressing formation of nitrogen oxide synthetase
03/12/2003CN1401316A Use of trans-diphenylethene derivs in preventing and treating liver fibrosis
03/12/2003CN1102927C Prepn. of 1-butyl-4-piperidinylmethylamine
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal
03/11/2003US6531134 Mammalian milk growth factor
03/11/2003CA2346647C Treatment of dyspepsia
03/11/2003CA2264254C Phosphinic acid amides as matrix metalloprotease inhibitors
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 1258